# THIOTEPA
> **ANDA211831** · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2021-12-08
## Drug
- **FDA Application Number:** ANDA211831
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** THIOTEPA
- **Generic name:** Thiotepa
- **Active ingredients:** THIOTEPA
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** REGCON HOLDINGS
- **First approval:** 2021-12-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211831)
---
*AI Analytics · CC0 1.0*